Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer

THOR-2 Cohort 1 Investigators

Research output: Contribution to journal › Article › peer-review

29 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry